Evidence map›Paper›PMID 26266824›Full record

ArticleACS nano2015

Symmetry Controlled, Genetic Presentation of Bioactive Proteins on the P22 Virus-like Particle Using an External Decoration Protein.

Benjamin Schwarz, Patrick Madden, John Avera, Bridget Gordon, Kyle Larson, Heini M Miettinen, Masaki Uchida, Ben LaFrance, Gautam Basu, Agnieszka Rynda-Apple and 1 more

Open access · greenAbstract read
In one paragraph

Article in ACS nano, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
8.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 76 citations in OpenAlex.

  1. Chemical reviews · 2026
    Review
  2. Article
  3. Templated trimerization of the phage L decoration protein on capsids.Protein science : a publication of the Protein Society · 2025
    Article
  4. Templated trimerization of the phage L decoration protein on capsids.bioRxiv : the preprint server for biology · 2024
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Benjamin SchwarzDepartment of Chemistry, Indiana University , 800 E. Kirkwood Avenue, Bloomington, Indiana 47405, United States.
Patrick MaddenDepartment of Chemistry and Biochemistry, Montana State University , PO Box 173400, Bozeman, Montana 59717, United States.
John AveraDepartment of Chemistry, Indiana University , 800 E. Kirkwood Avenue, Bloomington, Indiana 47405, United States.
Bridget GordonBiOptix Inc. , 1775 38th Street, Boulder, Colorado 80301, United States.
Kyle LarsonDepartment of Microbiology and Immunology, Montana State University , PO Box 173520, Bozeman, Montana 59717, United States.
Heini M MiettinenDepartment of Microbiology and Immunology, Montana State University , PO Box 173520, Bozeman, Montana 59717, United States.
Masaki UchidaDepartment of Chemistry, Indiana University , 800 E. Kirkwood Avenue, Bloomington, Indiana 47405, United States.
Ben LaFranceDepartment of Chemistry and Biochemistry, Montana State University , PO Box 173400, Bozeman, Montana 59717, United States.
Gautam BasuDepartment of Biophysics, Bose Institute , Kolkata 700054, India.
Agnieszka Rynda-AppleDepartment of Microbiology and Immunology, Montana State University , PO Box 173520, Bozeman, Montana 59717, United States.
Trevor DouglasDepartment of Chemistry, Indiana University , 800 E. Kirkwood Avenue, Bloomington, Indiana 47405, United States.
Montana State University · USIndiana University Bloomington · USBioptix (United States) · USBose Institute · IN

Funding

Phage-based targeted imaging probes and their application to vascular diseasesR01EB012027 · NIBIB · TRUSTEES OF INDIANA UNIVERSITY · PI DOUGLAS, TREVOR · 2011 to 2014
$2.6M
Engineered virus-like nanoparticles targeting immunity needed for pan flu vaccineR01AI104905 · NIAID · TRUSTEES OF INDIANA UNIVERSITY · PI DOUGLAS, TREVOR, JUTILA, MARK A · 2013 to 2017
$2.3M
NIAID NIH HHS R01 AI104905NIBIB NIH HHS R01 EB012027
6 · The paper itself

Abstract

Viruses use spatial control of constituent proteins as a means of manipulating and evading host immune systems. Similarly, precise spatial control of proteins encapsulated or presented on designed nanoparticles has the potential to biomimetically amplify or shield biological interactions. Previously, we have shown the ability to encapsulate a wide range of guest proteins within the virus-like particle (VLP) from Salmonella typhimurium bacteriophage P22, including antigenic proteins from human pathogens such as influenza. Expanding on this robust encapsulation strategy, we have used the trimeric decoration protein (Dec) from bacteriophage L as a means of controlled exterior presentation on the mature P22 VLP, to which it binds with high affinity. Through genetic fusion to the C-terminus of the Dec protein, either the 17 kDa soluble region of murine CD40L or a minimal peptide designed from the binding region of the "self-marker" CD47 was independently presented on the P22 VLP capsid exterior. Both candidates retained function when presented as a Dec-fusion. Binding of the Dec domain to the P22 capsid was minimally changed across designed constructs, as measured by surface plasmon resonance, demonstrating the broad utility of this presentation strategy. Dec-mediated presentation offers a robust, modular means of decorating the exposed exterior of the P22 capsid in order to further orchestrate responses to internally functionalized VLPs within biological systems.

Indexed as

AnimalsBacteriophage lambdaBacteriophage P22Capsid ProteinsCD40 LigandCD47 AntigenHumansMicePeptidesRecombinant Fusion ProteinsSalmonella typhimuriumVirionCapsid ProteinsCD40 LigandCD47 AntigenPeptidesRecombinant Fusion Proteinsbacteriophage L decoration protein (dec)bacteriophage P22CD40L (CD154)polyvalent displaySPRvirus-like particle

Identifiers

PMID26266824
PMCPMC4863989
OpenAlexW2409894392

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.